Home
Dr. Philip C. Halverson
Publications
Philip C. Halverson
Internal Medicine
612-338-3333
825 Nicollet Mall Ste 1149
Minneapolis, MN 55402
Save
Share
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 2 publications
Filter
(0)
Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.
Safety of Rimegepant, an Oral CGRP Receptor Antagonist, Plus CGRP Monoclonal Antibodies for Migraine.
Journal:
Headache
Published:
June 03, 2020
VIEW PUBLICATION
The evaluation of the correct use and ease-of use of the ELLIPTA DPI in children with asthma.
The evaluation of the correct use and ease-of use of the ELLIPTA DPI in children with asthma.
Journal:
Pediatric pulmonology
Published:
March 18, 2020
VIEW PUBLICATION
Showing 1-2 of 2
Last Updated: 09/26/2026